V8 Peptides — Engineered Performance
Research Library
How to Reconstitute TB-500: A Laboratory Guide
TB-500Reconstitution & Handling

How to Reconstitute TB-500: A Laboratory Guide

V8 Peptides Research TeamUpdated

Compiled from peer-reviewed literature and manufacturer analytical data for laboratory research reference.

Quick answer

How is TB-500 reconstituted in the laboratory? The vial holds lyophilized powder (10 mg per the product page). Bring the sealed vial to room temperature, choose a diluent suited to the experiment (sterile water or bacteriostatic water for stocks; the assay medium for final dilutions), run the diluent down the vial wall, swirl gently without shaking, then aliquot and store cold. Concentration is a formula: vial mass in mg divided by diluent volume in mL gives mg/mL, with the calculator doing the arithmetic. Published preclinical papers on the parent protein, thymosin β4, describe their preparations in their methods sections and are cited below. For laboratory research use only.

TB-500 is the synthetic 17–23 fragment of thymosin β4, Ac-LKKTETQ. Because it is a short, hydrophilic, acetylated heptapeptide, it is a relatively forgiving peptide to reconstitute, but good technique still protects concentration accuracy and sample integrity. This guide covers the bench steps, the formulas for concentration planning, aliquoting and storage, and what published preclinical studies on thymosin β4 report about how their materials were prepared. It does not recommend any amount for any purpose; planning is the researcher’s own, in the researcher’s own system. Background on the compound is in the TB-500 research overview, and the general method is in how to reconstitute a lyophilized peptide.

What is in the vial

Per the TB-500 product page: 10 mg of lyophilized powder, purity stated as ≥98% (HPLC), formula C38H68N10O14, sequence Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln, supplied in a sealed clear glass research vial. Storage is stated as refrigerate at 2–8 °C, −20 °C for long-term, protect from heat, moisture and light. The molecular weight is about 889 Da, which matters for molar calculations. The cake may look small, fluffy or collapsed at the bottom of the vial; appearance varies with the lyophilization cycle and does not by itself indicate a problem (what a normal peptide vial looks like).

Equipment and preparation

Assemble everything before opening the vial so that the cold cake spends little time exposed to room air.

  • The sealed vial, brought to room temperature for a period before opening so condensation does not form on the cake.
  • Diluent, labeled with lot and date.
  • Sterile, low-binding tubes for aliquots; short peptides adsorb to some plastics.
  • Calibrated pipettes and sterile tips.
  • Alcohol wipes for the stopper and a clean work surface.
  • A labeled log sheet: lot, date, diluent, volume, calculated concentration.

Choosing a diluent

The diluent choice depends on how the stock will be used. Sterile water is simple and free of additives, which suits a stock that will be aliquoted and frozen right away. Bacteriostatic water contains a preservative (benzyl alcohol) that suppresses microbial growth in a vial that will be entered multiple times, but the preservative can interfere with some cell assays, so check compatibility (bacteriostatic water explained). For cell work, the final dilution is usually made in assay medium, and a matched vehicle control carrying the same share of stock diluent is required. A buffered diluent may be chosen for pH control; TB-500 has no cysteine or methionine and a simple acyl cap, so it has few chemical demands on the buffer.

DiluentSuited toCautions
Sterile waterSingle-use stocks, aliquoted and frozenNo preservative; do not re-enter repeatedly
Bacteriostatic waterMulti-entry stock vialsPreservative can affect sensitive cell assays
Buffered saline or assay mediumFinal working dilutionsPrepare fresh; medium components may interact
Dilute acid or baseNot needed for this peptideUnneeded pH extremes can hydrolyze peptides

Step-by-step

  1. Equilibrate. Let the sealed vial reach room temperature.
  2. Clean. Wipe the stopper with alcohol and let it dry.
  3. Calculate. Decide the stock concentration (see below) and the volume of diluent it implies.
  4. Add diluent slowly. Run it down the inside wall of the vial instead of onto the cake.
  5. Dissolve gently. Swirl or roll the vial; do not shake or vortex, which creates foam and interface stress.
  6. Inspect. The solution should be clear and colorless. Haze, particles or color are recorded and investigated.
  7. Aliquot. Divide into single-use portions in low-binding tubes, labeled with lot, concentration and date.
  8. Store. Refrigerate working aliquots or freeze reserve aliquots, protected from light.

The general reasoning behind each step, including why wall-directed addition and gentle swirling protect peptides, is in the reconstitution guide.

Concentration arithmetic as formulas

Use formulas and let the calculator do the computation. The relationships are these:

QuantityFormulaNotes
Stock mass concentration (mg/mL)vial mass (mg) ÷ diluent volume (mL)Assumes the whole vial content is dissolved and the added volume dominates
Diluent volume for a target concentrationvial mass (mg) ÷ target concentration (mg/mL)Rearrangement of the above
Molar concentration (mmol/L)mass concentration (mg/mL) ÷ molar mass (g/mol) × 1000Molar mass about 889 g/mol per the product page
Dilution into assayC1 × V1 = C2 × V2C1 stock, C2 final, V2 final volume
Vehicle share in assaystock volume added ÷ final volumeCarry the same share into the vehicle control

Two practical notes. First, the mass in the vial is the label amount of peptide solid, which includes counter-ions and some residual water, so the actual peptide content is somewhat lower than the nominal mass; where precise molarity matters, quantify the stock by amino acid analysis or UV absorbance. Second, because TB-500 lacks tryptophan and tyrosine, it has little UV absorbance at 280 nm, so absorbance at 280 nm is not a useful quantitation method; use a peptide-bond reading at 205–220 nm or amino acid analysis.

Aliquoting, freezing and thawing

Freezing in single-use aliquots avoids repeated freeze–thaw of the whole stock (Bhatnagar et al., 2007, describe the stresses of freezing for protein and peptide formulations). Freeze promptly after reconstitution, label clearly and thaw each aliquot once. A thawed aliquot is kept cold and used within the experiment or discarded. Low-binding tubes limit adsorptive loss from dilute solutions (Goebel-Stengel et al., 2011). No validated shelf life has been published for reconstituted research-grade TB-500, so verify stocks by HPLC where concentration is critical; see how long reconstituted peptides last and storing research peptides.

What published preclinical studies reported

The preclinical literature on this peptide family was largely conducted with full-length thymosin β4, not the TB-500 fragment. The rat dermal wound study reported thymosin β4 applied topically or by the intraperitoneal route in saline-controlled experiments (Malinda et al., 1999), and a mouse corneal study reported topical application to the eye in a defined wound model (Sosne et al., 2001). In vitro studies of actin binding and migration used purified or recombinant protein in buffered solutions (Sun et al., 1996; Huff et al., 2001). The exact preparation, concentration and timing in each case is given in the methods of the original paper and is specific to that experiment. Nothing here is a recommendation: the papers are cited so that a reader can see how those groups described their materials and can design a comparable control set of their own. The wound studies are discussed in more detail in TB-500 versus thymosin β4, and a comparison with another tissue-response peptide is in BPC-157 versus TB-500.

Working with the stock in assays

The step between stock and assay is where many concentration errors arise. Make working dilutions from the stock, not from the vial, using the dilution formula, and prepare enough of each working solution for the whole experiment so that all replicates receive the same preparation. For a cell-based migration or scratch assay, add the peptide to medium at the final concentration immediately before use, mix by gentle inversion, and keep the volume of stock added small relative to the medium so that the vehicle share is the same in every well. For binding or biochemical assays, match the buffer of the working solution to the assay buffer and record the pH. If an experiment compares TB-500 with the parent protein, match the arms on a molar basis rather than by mass, because the fragment is far smaller than the 43-residue protein.

Peptide solutions should be kept on ice during the working session and not left at room temperature for long periods. When several peptides are handled in the same session, label tubes clearly and change tips between them to prevent cross-contamination, which is a quiet source of unexpected results.

Troubleshooting

Typical problems and first responses are listed below.

ObservationLikely causeResponse
Cake slow to dissolveInsufficient time, cold diluentSwirl longer at room temperature; avoid heating
Foam after dissolvingDiluent added too fast or vial shakenLet it settle; swirl gently in future
Haze or particlesContamination, wrong diluent, degradationDo not use; record lot and observation
Concentration lower than expectedAdsorption, pipetting error, hydration of solidUse low-binding tubes; quantify the stock
Variable assay results between aliquotsRepeated thawing, inconsistent aliquot volumesSingle-use aliquots; log thaw events

Documentation

Record the lot, date received, diluent and lot, calculated concentration, number of aliquots, storage location and any deviations. Lot certificates, where published, are in the COA library; how to read a COA explains the fields, and TB-500 purity testing covers the analytical side. Vial and stock records are what let a result be repeated, and a result that cannot be repeated is of little use. All TB-500 is supplied for laboratory research use only.

Frequently asked questions

What diluent should I use to reconstitute TB-500?

Sterile water suits a stock that is aliquoted and frozen; bacteriostatic water suits a vial that will be entered several times. For cell work, check preservative compatibility and run a matched vehicle control.

How do I calculate the stock concentration?

Divide the vial mass in mg by the diluent volume in mL to get mg/mL. The reconstitution calculator performs the arithmetic.

What is the molecular weight of TB-500?

About 889 Da according to the product page, with the formula C38H68N10O14.

Should I shake the vial to dissolve the powder?

No. Add diluent down the wall and swirl gently; shaking creates foam and interface stress.

How should the stock be stored?

The product page states: refrigerate at 2–8 °C, −20 °C for long-term, protect from heat, moisture and light. Aliquot to avoid repeated freeze–thaw.

How long does reconstituted TB-500 last?

No validated shelf life has been published for the research-grade material. Verify by HPLC where concentration matters.

Why is 280 nm absorbance a poor quantitation method for TB-500?

The sequence has no tryptophan or tyrosine, so absorbance at 280 nm is very low. Peptide-bond absorbance at 205–220 nm or amino acid analysis is more appropriate.

What did published studies use?

Studies on thymosin β4 report their routes and preparations in their methods; the wound studies described topical and intraperitoneal administration in rodents. They used the full protein, not the fragment.

Why use low-binding tubes?

Small peptides adsorb to plastic, and the proportional loss is greatest at low concentration.

What should I do if the solution is cloudy?

Do not use it. Record the lot and observation and consult the certificate of analysis where published.

Related reading: TB-500 Preclinical Studies: Fragment vs Thymosin Beta-4, History of TB-500 and Thymosin β4 Research, TB-500: Angiogenesis and Cell Migration Assay Guide.

References

  1. Bhatnagar BS, Bogner RH, Pikal MJ. Protein stability during freezing: separation of stresses and mechanisms of stabilization. Pharm Dev Technol. 2007;12(5):505-523. doi:10.1080/10837450701481157
  2. Goebel-Stengel M, Stengel A, Taché Y, Reeve JR Jr. The importance of using the optimal plasticware and glassware in studies involving peptides. Anal Biochem. 2011;414(1):38-46. doi:10.1016/j.ab.2011.02.009
  3. Malinda KM, Sidhu GS, Mani H, et al. Thymosin β4 accelerates wound healing. J Invest Dermatol. 1999;113(3):364-368. doi:10.1046/j.1523-1747.1999.00708.x
  4. Sosne G, Chan CC, Thai K, et al. Thymosin beta 4 promotes corneal wound healing and modulates inflammatory mediators in vivo. Exp Eye Res. 2001;72(5):605-608. doi:10.1006/exer.2000.0985
  5. Sun HQ, Kwiatkowska K, Yin HL. β-Thymosins are not simple actin monomer buffering proteins. J Biol Chem. 1996;271(16):9223-9230. doi:10.1074/jbc.271.16.9223
  6. Huff T, Müller CS, Otto AM, Netzker R, Hannappel E. β-Thymosins, small acidic peptides with multiple functions. Int J Biochem Cell Biol. 2001;33(3):205-220. doi:10.1016/s1357-2725(00)00087-x
  7. Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544-575. doi:10.1007/s11095-009-0045-6

Research Use Only. All products are sold strictly for laboratory research and development purposes only. Not for human or animal consumption. Not a drug, food, or cosmetic. By purchasing, you affirm you are a qualified researcher or institution.